| Title | Schedules of Controlled Substances: Placement of 4-hydroxy-N,N-diisopropyltryptamine (4-OH-DiPT), 5-methoxy-alpha-methyltryptamine (5-MeO-AMT), 5-methoxy-N-methyl-N-isopropyltryptamine (5-MeO-MiPT), 5-methoxy-N,N-diethyltryptamine (5-MeO-DET), and N,N-diisopropyltryptamine (DiPT) in Schedule I; Withdrawal and Notice of Hearing |
| ToC Doc | Placement of 4-hydroxy-N,N-diisopropyltryptamine (4-OH-DiPT), 5-methoxy-alpha-methyltryptamine (5-MeO-AMT), 5-methoxy-N-methyl-N-isopropyltryptamine (5-MeO-MiPT), 5-methoxy-N,N-diethyltryptamine (5-MeO-DET), and N,N-diisopropyltryptamine (DiPT) in Schedule I; Withdrawal and Notice of Hearing |
| Docket Number | 2022-16102 |
| Type | Proposed Rule |
| Subject | Schedules of Controlled Substances: Placement of 4-hydroxy-N,N-diisopropyltryptamine (4-OH-DiPT), 5-methoxy-alpha-methyltryptamine (5-MeO-AMT), 5-methoxy-N-methyl-N-isopropyltryptamine (5-MeO-MiPT), 5-methoxy-N,N-diethyltryptamine (5-MeO-DET), and N,N-diisopropyltryptamine (DiPT) in Schedule I; Withdrawal and Notice of Hearing |
| Publication Date | 2022-07-27 |
| Last Updated Date | 2022-07-26 08:15:08 -0400 |
| Last Public Inspection | 2022-07-26 |
| Filed At | 2022-07-26T08:45:00.000-04:00 |
| 2022-16102_PI.pdf (101406 bytes) | |
| Download | TXT / HTML / JSON |
| Number of Pages | 3 |
| Filing Type | regular |
| Agencies | Drug Enforcement Administration |
You can find the raw source document below...